Status:
COMPLETED
A Prospective Chart Review to Validate the WFIRS (Weiss Functional Impairment Rating Scale)
Lead Sponsor:
University of British Columbia
Collaborating Sponsors:
Eli Lilly and Company
Purdue Pharma LP
Conditions:
Attention-Deficit/Hyperactivity Disorder
Eligibility:
All Genders
7+ years
Brief Summary
The purpose of the study is to evaluate the psychometric validation of the Weiss Functional Impairment Rating Scale and the Weiss Symptom Record. It is hypothesized that the Weiss Functional Impairmen...
Detailed Description
The measures for this rating scale were developed at the request of the Canadian Attention Deficit Disorder Resource Alliance to provide clinician friendly tools free of charge as a way of improving s...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Compliance to complete the WFIRS is key to inclusion.
Exclusion
Key Trial Info
Start Date :
July 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2011
Estimated Enrollment :
220 Patients enrolled
Trial Details
Trial ID
NCT00885807
Start Date
July 1 2006
End Date
April 1 2011
Last Update
June 20 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Provincial ADHD Program, BC Children's & Women's Health Centre
Vancouver, British Columbia, Canada